These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the strategy of focusing on ACKR3 as a unique solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked disorders.Name your collection: Name have to be lower than